Diagnostic performance of In-111 capromab pendetide SPECT/CT in localized and metastatic prostate cancer.

@article{Rieter2011DiagnosticPO,
  title={Diagnostic performance of In-111 capromab pendetide SPECT/CT in localized and metastatic prostate cancer.},
  author={William J. Rieter and Thomas E. Keane and Mark A Ahlman and Clayton Tyler Ellis and Kenneth M. Spicer and Leonie L. Gordon},
  journal={Clinical nuclear medicine},
  year={2011},
  volume={36 10},
  pages={872-8}
}
PURPOSE To determine the diagnostic performance of In-111 capromab pendetide single photon emission computed tomography/computed tomography (SPECT/CT), in the prostate gland, seminal vesicles, and lymph nodes via correlation to a gold standard of histopathology. MATERIALS AND METHODS In this study, we retrospectively reviewed all In-111 capromab pendetide SPECT/CT acquired at our institution for dedicated histopathology within a 4-month period. Statistical measures of performance were… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…